Ezaki Minoru, Wada Hideo, Ichikawa Yuhuko, Ikeda Nozomi, Shiraki Katsuya, Yamamoto Akitaka, Moritani Isao, Shimaoka Motomu, Shimpo Hideto
Department of Central Laboratory, Mie Prefectural General Medical Center, Yokkaichi 510-0885, Japan.
Department of General and Laboratory Medicine, Mie Prefectural General Medical Center, Yokkaichi 510-0885, Japan.
J Clin Med. 2023 Mar 30;12(7):2597. doi: 10.3390/jcm12072597.
Soluble fibrin (SF) is a form of fibrinogen that is activated by thrombin and is considered to be useful for the diagnosis of the prethrombotic state or thrombosis.
Plasma levels of fibrin-related markers (FRMs), such as SF, D-dimer, fibrinogen, and fibrin degradation prioduct (FDP) levels in critically ill patients, were examined for the diagnosis of disseminated intravascular coagulation (DIC), venous thromboembolism (VTE), peripheral arterial thromboembolism (PATE), acute myocardial infarction (AMI), and acute cerebral infarction (ACI).
FRMs showed the usefulness in diagnosing DIC and VTE and the cutoff values of D-dimer, FDP, and SF for DIC were 7.2-7.8 μg/mL, 10.0 μg/mL, and 9.5 μg/mL, respectively. The cutoff values of D-dimer and FDP for VTE were similar to the 97.5th percentile values of healthy volunteers, while the cutoff value of SF was 6.9 μg/mL. In AMI and ACI, the cutoff values of D-dimer and FDP were lower than the 97.5 percentile values of healthy volunteers. A receiver operating characteristic analysis for all thrombosis cases showed that an adequate cutoff value in only SF among FRMs was higher than the confidence interval of healthy volunteers. Only SF had high sensitivity for thrombosis, as the FDP/SF ratio was markedly low for ACI, AMI and VTE.
FRMs, especially D-dimer and FDP, were useful for diagnosing thrombosis with hyperfibrinolysis (e.g., DIC). As SF showed high sensitivity for predominantly thrombotic diseases, including arterial thrombosis, such as ACI and AMI, a high SF value suggests the possibility of an association with thrombosis. Finally, SF is the most useful marker for raising suspicion of an association with thrombosis, especially arterial thrombosis.
可溶性纤维蛋白(SF)是一种由凝血酶激活的纤维蛋白原形式,被认为对血栓前状态或血栓形成的诊断有用。
检测危重症患者血浆中纤维蛋白相关标志物(FRMs),如SF、D-二聚体、纤维蛋白原和纤维蛋白降解产物(FDP)水平,以诊断弥散性血管内凝血(DIC)、静脉血栓栓塞症(VTE)、外周动脉血栓栓塞症(PATE)、急性心肌梗死(AMI)和急性脑梗死(ACI)。
FRMs对DIC和VTE的诊断有帮助,DIC的D-二聚体、FDP和SF的临界值分别为7.2 - 7.8μg/mL、10.0μg/mL和9.5μg/mL。VTE的D-二聚体和FDP临界值与健康志愿者的第97.5百分位数相似,而SF的临界值为6.9μg/mL。在AMI和ACI中,D-二聚体和FDP的临界值低于健康志愿者的第97.5百分位数。对所有血栓形成病例的受试者工作特征分析表明,FRMs中仅SF的合适临界值高于健康志愿者的置信区间。仅SF对血栓形成具有高敏感性,因为ACI、AMI和VTE的FDP/SF比值明显较低。
FRMs,尤其是D-二聚体和FDP,对诊断伴有纤溶亢进的血栓形成(如DIC)有用。由于SF对包括动脉血栓形成(如ACI和AMI)在内的主要血栓性疾病具有高敏感性,SF值升高提示可能与血栓形成有关。最后,SF是最有助于怀疑与血栓形成相关,尤其是动脉血栓形成的标志物。